Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2021-02-23 Director's Dealing
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj Managers' Transactions
Director's Dealing Classification · 100% confidence The document is titled 'Biohit Oyj Managers' Transactions' and details a specific share disposal by the CEO, Semi Korpela. It includes standard regulatory fields for insider trading disclosures such as transaction date, venue, volume, and price. This fits the definition of a Director's Dealing (DIRS) report.
2021-02-23 English
Biohit Oyj Johdon liiketoimet
Director's Dealing Classification · 100% confidence The document is titled 'Biohit Oyj Johdon liiketoimet' (Biohit Oyj Manager's Transactions) and details a specific share transaction by the CEO, Semi Korpela. It includes the transaction date, volume, price, and instrument type, which are standard requirements for reporting insider dealings under market abuse regulations. This fits the definition of 'Director's Dealing' (DIRS).
2021-02-23 Finnish
Tilinpäätöstiedote ENG-2020.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Financial Statement Release' for Biohit Oyj covering the fiscal year 2020. It contains comprehensive financial data, including revenue, EBITDA, balance sheet summaries, and key performance indicators for both the full year and the second half (H2). It also includes management commentary, outlook for 2021, and risk factors. This aligns perfectly with the definition of an Interim/Quarterly Report (IR), which covers periods shorter than a full fiscal year or provides substantive financial analysis for a specific reporting period. FY 2020
2021-02-17 English
Biohit group financial statement release 2020
Annual Report Classification · 95% confidence The document is a 'Financial Statement Release' for the full fiscal year 2020, containing comprehensive financial data, balance sheets, income statements, management commentary, and outlook. It is not a short announcement (over 32,000 characters) and provides substantive financial analysis, fitting the definition of an Interim/Quarterly Report (IR) or Annual Report (10-K). Given it covers the full fiscal year 2020 and is titled 'Financial Statement Release', it functions as the primary annual financial reporting document. FY 2020
2021-02-17 English
Tilinpäätöstiedote-FI-2020.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a 'Tilinpäätöstiedote' (Financial Statements Release) for the fiscal year 2020, published by Biohit Oyj. It contains comprehensive financial data, including income statements, balance sheets, key performance indicators (KPIs), management commentary, and outlook for the upcoming year. It is a substantive financial report covering a period shorter than a full fiscal year (in this case, the full year 2020, but structured as a periodic financial release). Given the detailed financial tables and management analysis, it fits the definition of an Interim/Quarterly Report (IR) in the context of periodic financial reporting. FY 2020
2021-02-17 Finnish
Biohit-konsernin tilinpäätöstiedote 2020
Audit Report / Information Classification · 98% confidence The document is titled 'Biohit-konsernin tilinpäätöstiedote 2020' (Biohit Group Financial Statement Release 2020). It provides a comprehensive summary of the company's financial performance for the fiscal year 2020, including revenue, operating profit, balance sheet details, and management commentary. It is a formal financial reporting document released by the company to the public, which fits the definition of an Earnings Release (ER) or a preliminary financial report. Given the depth of the data provided (tables, segment reporting, and management outlook), it is a standard financial results announcement. FY 2020
2021-02-17 Finnish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.